State Of Wyoming Zentalis Pharmaceuticals, Inc. Transaction History
State Of Wyoming
- $778 Million
- Q2 2025
A detailed history of State Of Wyoming transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wyoming holds 73,797 shares of ZNTL stock, worth $117,337. This represents 0.01% of its overall portfolio holdings.
Number of Shares
73,797
Previous 45,176
63.35%
Holding current value
$117,337
Previous $71,000
19.72%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ZNTL
# of Institutions
124Shares Held
60.6MCall Options Held
0Put Options Held
22K-
Matrix Capital Management Company, LP Waltham, MA14MShares$22.2 Million8.42% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$7.66 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$5.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$4.59 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.8MShares$4.45 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $90.6M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...